Therapeutic Areas of Excellence
Over the past the 25 years, members of the DVCR team have developed significant medical, scientific and operational expertise in the conduct of clinical studies in the following therapeutic areas:
Dr. Vince Clinical Research (DVCR) is a physician led, full-service CRO specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as CNS, psychiatry, neurology, substance use disorders, pain, cardiometabolic disorders, pulmonary, dermatology, allergy, immunology, infectious diseases and many others.
Members of our medical and scientific team have served as investigators on well over 2,000 clinical trials across all phases of research and indications. This collective experience gives us the requisite knowledge to provide expert scientific, medical and operational guidance in the execution of clinical studies at both DVCR’s clinical pharmacology unit and at our global network of strategic site partners.
This extensive clinical research expertise positions DVCR as the premier early phase CRO partner to biopharmaceutical companies of all sizes. With a commitment to both science and speed, our team provides strategic and operational guidance to ensure your protocol is more recruitable, operationally efficient and financially achievable.
l
CNS, Psychiatry & Neurology
Investigators on our team have participated in hundreds of clinical studies for psychiatric and neurologic indications across all phases of research. Further, they possess a deep understanding of the indications, patient populations, procedures, assessments and questionnaires associated with CNS clinical trials.
l
Substance Use Disorders (SUD) & Addiction
DVCR’s Chief Medical Officer & CEO, Brad Vince, DO, has been involved in over 50 Phase I/II trials with overnight confinement in recreational and dependent substance users. Our investigators, clinical operations, pharmacy, laboratory and recruitment staff have significant expertise in these types of trials. The majority of this team have also been involved in studies conducted under long-term contracts held with NIDA and FDA. DVCR’s volunteer database represents one of the largest populations of substance users in North America.
l
Allergy & Immunology
Led by William Lavery, MD, PhD, an experienced clinical research investigator who is board-certified in Allergy and Immunology, DVCR conducts studies in allergy and immunology indications in both healthy volunteers and patient populations at our Phase 1 clinical pharmacology unit and at our global network of strategic site partners.
l
Cardiometabolic
l
Pain
Led by Lynn Webster, MD, an internationally-recognized clinical research expert in pain and addiction medicine, the DVCR team offers broad expertise in pain therapeutics and conducts a variety of human and experimental pain models to study the pharmacodynamics of pain compounds. Our team has conducted dozens of pain-related studies including studies with new treatments for pain and are skilled in the administration and data collection of multiple pain intensity assessments.
l
Pulmonary
DVCR’s investigators have participated in several pulmonary trials in healthy volunteers and patient populations such as asthma and COPD across all phases of clinical development. Led by our Medical Director and Principal Investigator Steven Hull, MD, a pulmonologist with 35 years of experience, our clinical operations team are well-versed in the technique, equipment and required coaching to ensure the collection of high-quality data for respiratory assessments.
l
Dermatology
Members of our investigator team have participated in dozens of trials in dermatologic indications, with many studies involving biopsies, skin assessments and photography. For trials in dermatology, DVCR leverages board-certified dermatologists with experience in clinical research for indications such as atopic dermatitis and psoriasis.
l
Infectious Diseases
Our investigators have served on over 50 clinical studies evaluating antivirals and vaccines across all phases of research for infectious diseases such as influenza, hepatitis B, hepatitis C, herpes zoster and many others. These studies include complex early phase trials and government-funded projects.